Bristol fusion startup Astral Systems has raised £23mn to scale the medical isotopes that cancer scans depend on. The Astral Systems £23M round backs a rare fusion company that already runs reactors and earns revenue. Most fusion companies promise clean power in a decade or two. Astral Systems is trying something different, and getting paid […]

This story continues at The Next Web